A maker of pasture-raised eggs, butter, and hard-boiled eggs sold in tens of thousands of stores across the US, sourced from a network of over 600 small family farms. It began in 2007 when founder Matt O'Hayer started with just 20 Rhode Island Red hens on a 27-acre Austin farm, living in an RV on the property. The company is a Certified B Corporation and public benefit corporation, and its main Missouri processing plant is nicknamed Egg Central Station.
Gross margin collapsed to 6.6% as an industry-wide egg oversupply forced excess inventory into low-price channels and triggered a $7.8M butter exit charge.
Vital Farms swung to a net loss of $31.1 million as an egg glut crushed pricing power. fell 10% to $166.0 million and contracted 32.3 points to 6.6%, driven by an unfavorable sales mix from dumping excess eggs into breaker and wholesale channels and a $7.8 million charge to exit the butter business. The company is now halting construction of its second facility and paying farmers to reduce flocks to preserve cash.
Key takeaways
fell to 6.6% from 38.9% a year ago, as an industry-wide shell egg oversupply forced the company to sell excess eggs into lower-priced breaker and wholesale channels, while a $7.8 million charge for the wind-down of the butter business further compressed the result.
Net fell 10.1% to $166.0 million, with management attributing the decline to lower retail shell egg volumes, partially offset by a slight price and mix benefit.
Section summaries
Management's Discussion and Analysis
Vital Farms swung to a net loss of $31.1M in Q2 FY2026 as an industry-wide egg oversupply crushed margins and forced a $7.8M butter exit charge.
⌄
Net fell 10% to $166.0M, driven by a volume decline in retail shell egg sales, partially offset by a slight price/mix benefit.
collapsed to 7% from 39% due to higher input costs, unfavorable sales mix from dumping excess eggs into low-price breaker/wholesale channels, and a $7.8M butter .
The company swung to a net loss of $31.1 million from of $16.6 million in the prior-year quarter, as the collapse was compounded by a 4% increase in selling, general and administrative expenses to $40.4 million.
In response to the oversupply, management is implementing supply control initiatives including paying contract farmers to reduce flock sizes, halting construction of the Vital Crossroads processing facility, and pausing new accelerator farm development.
was a $44.1 million outflow, deepening from a $7.6 million outflow a year ago, as on the new facility continued and consumed cash.
Post-quarter, the company entered into a new $125 million term loan and a $60 million to fund operations and the remaining $55 million to $80 million in Vital Crossroads , and terminated its $100 million stock program after buying back $35 million in shares.
What changed
The oversupply flagged as a risk in Q1 FY2026 intensified: fell a further 21.7 points sequentially to 6.6%, and the net loss widened from $1.5 million to $31.1 million, as the unfavorable sales mix from breaker and wholesale egg sales deepened.
The supply control initiatives announced in Q1 FY2026 were escalated: the company is now paying farmers to reduce flocks and has halted construction of the Vital Crossroads facility entirely, rather than merely slowing it.
The butter business wind-down, first disclosed in Q1 FY2026, resulted in a $7.8 million charge this quarter, making the exit cost explicit.
Cash and equivalents fell a further 42% sequentially to $21.2 million, down 80% , before the post-quarter addition of a $125 million term loan and a $60 million .
The material weakness in internal controls over the process, remediated in FY2025, did not reappear; the risk factors now center on the oversupply-driven and a new securities class action filed in March 2026.
What to watch
Whether the supply control initiatives—paying farmers to reduce flocks and halting Vital Crossroads construction—stabilize above 10% in the next quarter, or whether the industry oversupply continues to force eggs into low-price channels.
The pace of cash burn against the post-quarter liquidity position, including the $125 million term loan and $60 million , and whether the remaining $55 million to $80 million in Vital Crossroads is deferred or drawn down.
Any further spread of Egg Drop Syndrome or avian influenza beyond the farms already affected, given that shell eggs remain approximately 92% of net and a supply disruption could compound the oversupply problem.
The progress and cost of the putative securities class action filed in March 2026, and whether it distracts management or leads to a material settlement.
The company is implementing supply control measures, paying farmers to reduce flocks, halting construction of the Vital Crossroads facility, and pausing new accelerator farm development.
Selling, general and administrative expenses rose 4% to $40.4M, driven by consulting fees for a feed cost savings program and higher technology costs, partially offset by lower .
Liquidity was bolstered post-quarter by a new $125M term loan and a $60M asset-backed , replacing the prior revolver, to fund operations and the $55M-$80M in remaining Vital Crossroads .
The company terminated its $100M stock program after buying back $35M in shares during the first half of the year.
Quantitative and Qualitative Disclosures About Market Risk
We are exposed to market risks in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily the result of fluctuations in…
⌄
We are exposed to market risks in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily the result of fluctuations in raw materials, ingredients, inflation and interest rates.
There have been no material changes in our exposure to market risk during the 13-week and 26-week periods ended June 28, 2026 from the information provided in Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk” in our latest Annual Report.
From time to time, we may become involved in legal proceedings arising in the ordinary course of our business. For additional information regarding legal proceedings, if any, see Note 21 “Commitments and Contingencies—Litigation” to our unaudited condensed consolidated financial…
⌄
From time to time, we may become involved in legal proceedings arising in the ordinary course of our business. For additional information regarding legal proceedings, if any, see Note 21 “Commitments and Contingencies—Litigation” to our unaudited condensed consolidated financial statements included elsewhere in this report.
42
Shell egg oversupply, margin compression, and recent net losses highlight material risks to revenue concentration, pricing power, and growth execution.
⌄
Shell eggs are ~92% of net , and an industry-wide oversupply in 2026 has caused declining , increased price gaps with competitors, and significant compression.
The company reported net losses of $1.5M and $31.1M in the two most recent 13-week periods, driven by higher cost of goods sold and the oversupply of .
A new securities class action and related derivative lawsuits were filed in March 2026 alleging violations of the Exchange Act, adding litigation risk and potential management distraction.
The company is halting construction of its Vital Crossroads processing facility and pausing new accelerator farm development to reduce in response to market conditions.
Concentration risk is high: a single Missouri facility (Egg Central Station) handles substantial shell egg processing, one distributor (UNFI) accounts for ~21% of net , and one supplier provides substantially all shell egg cartons.
Agricultural disease outbreaks remain a key threat, with 12 farms affected by Egg Drop Syndrome in fiscal 2025 and one in fiscal 2026, alongside ongoing HPAI risks.